U.S. stocks traded higher, with the Dow Jones gaining more than 100 points on Wednesday. Here are some big stocks recording losses in today’s session. Olaplex Holdings, Inc. (NASDAQ: OLPX) shares

Pre-Markets Give Some Back; Housing Starts Lower; PG, ABT Beat

02:35pm, Wednesday, 19'th Oct 2022 Zacks Investment Research
The markets seem in a mood to give back some of the boon they've garnered over the past 3 of 4 sessions.

Why Abbott Laboratories Stock Is Slumping Today

02:10pm, Wednesday, 19'th Oct 2022
A potential drop-off in COVID-19 testing sales is weighing on the healthcare giant's shares today.
While Abbott Laboratories beat analysts' expectations due to demand for Covid-19 at-home tests, a decline by its medical-device business and broader headwinds helped send its shares down.
Abbott Laboratories (NYSE:ABT ) Q3 2022 Earnings Conference Call October 19, 2022 9:00 AM ET Company Participants Scott Leinenweber - Vice President, Investor Relations, Licensing and Acquisition Robe

Abbott (ABT) Q3 Earnings and Revenues Surpass Estimates

12:45pm, Wednesday, 19'th Oct 2022 Zacks Investment Research
Abbott (ABT) delivered earnings and revenue surprises of 26.37% and 8.67%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Ready to Buy the Dip? This Healthcare Stock Is a Smart Buy

10:30am, Wednesday, 19'th Oct 2022 The Motley Fool
DexCom's latest products could drive lasting growth.
Abbott Laboratories reported better-than-expected third-quarter declines and raised its earnings guidance. But ABT stock tumbled.
With US stock futures trading mixed this morning on Wednesday, some of the stocks that may grab investor focus today are as follows: Wall Street expects Tesla, Inc. (NASDAQ: TSLA) to report quarterl
Abbott says sales of medical devices rose more than 11% in the third quarter.
Abbott Laboratories ABT, +1.41% said Wednesday that it had earnings of $1.4 billion, or $1.15 per share, in the third quarter of 2022, compared with $2.1 billion, or $1.40, in the same quarter a year

Abbott raises 2022 profit forecast for second time

07:35am, Wednesday, 19'th Oct 2022
Abbott Laboratories on Wednesday raised its annual earnings forecast for the second time, citing strong demand for medical devices and pharmaceutical products.
Upgrades According to Jefferies, the prior rating for Target Corp (NYSE:TGT) was changed from Hold to Buy. Target earned $0.39 in the second quarter, compared to $3.64 in the year-ago quarter. The cur
Apple, Abbott Laboratories, International Business Machines, Estee Lauder and Progressive are included in this Analyst Blog.

Q3 Earnings Scorecard and Analyst Reports for Apple, Abbott, IBM & Others

05:51pm, Monday, 17'th Oct 2022 Zacks Investment Research
Today's Research Daily features the Q3 earnings season scorecard and new research reports on Apple (AAPL), Abbott (ABT) and IBM (IBM) and others.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE